Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,442 | 177 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $436.75 | 34 | $0 (2021) |
| Novo Nordisk Inc | $338.40 | 23 | $0 (2022) |
| Lilly USA, LLC | $281.54 | 20 | $0 (2021) |
| Allergan, Inc. | $157.39 | 17 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $138.98 | 10 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $138.86 | 10 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $130.14 | 9 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $127.57 | 9 | $0 (2021) |
| Amgen Inc. | $118.83 | 8 | $0 (2022) |
| SANOFI PASTEUR INC. | $76.48 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $158.96 | 10 | AstraZeneca Pharmaceuticals LP ($44.79) |
| 2021 | $402.39 | 24 | Novo Nordisk Inc ($67.07) |
| 2020 | $427.53 | 26 | Novo Nordisk Inc ($80.17) |
| 2019 | $456.70 | 34 | GlaxoSmithKline, LLC. ($168.21) |
| 2018 | $348.63 | 28 | Lilly USA, LLC ($72.71) |
| 2017 | $647.77 | 55 | Allergan Inc. ($145.08) |
All Payment Transactions
177 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/31/2022 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Neuroscience | ||||||
| 03/11/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Cardiovascular | ||||||
| 02/15/2022 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Obesity | ||||||
| 02/10/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/24/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Endocrinology | ||||||
| 01/18/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/13/2022 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Obesity | ||||||
| 01/13/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Respiratory | ||||||
| 01/12/2022 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Virology & Specialty Care | ||||||
| 01/11/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Gastroenterology | ||||||
| 12/09/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: NEUROSCIENCE | ||||||
| 11/23/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Obesity | ||||||
| 11/18/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/02/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological), PNEUMOVAX 23, VAXELIS | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: VACCINE | ||||||
| 10/27/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/15/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2021 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: CONTRACEPTIVES | ||||||
| 09/24/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Diabetes | ||||||
| 09/08/2021 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: ALLERGY | ||||||
| 09/01/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Diabetes | ||||||
| 08/27/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: PRIMARY CARE | ||||||
| 08/24/2021 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: VACCINES | ||||||
| 08/09/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 08/05/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: Respiratory | ||||||
| 06/29/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 719 | 971 | $169,667 | $63,132 |
| 2022 | 12 | 667 | 885 | $136,630 | $59,242 |
| 2021 | 11 | 669 | 835 | $125,044 | $59,345 |
| 2020 | 12 | 557 | 709 | $112,035 | $46,410 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 188 | 395 | $99,145 | $32,100 | 32.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 113 | 113 | $29,945 | $14,117 | 47.1% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2023 | 51 | 51 | $6,786 | $3,648 | 53.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $4,407 | $2,099 | 47.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 12 | $4,476 | $1,904 | 42.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $6,392 | $1,791 | 28.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 14 | $4,970 | $1,648 | 33.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 50 | 50 | $2,200 | $1,473 | 66.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 77 | 77 | $2,772 | $1,374 | 49.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 24 | $4,272 | $1,071 | 25.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 89 | 129 | $1,469 | $1,053 | 71.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $504.00 | $353.40 | 70.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 30 | 31 | $1,364 | $324.80 | 23.8% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 11 | 11 | $833.00 | $128.21 | 15.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 20 | 22 | $132.00 | $48.40 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 190 | 374 | $85,493 | $32,235 | 37.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 101 | 101 | $20,985 | $12,936 | 61.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 90 | 107 | $16,489 | $5,913 | 35.9% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 44 | 44 | $3,564 | $3,016 | 84.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 91 | 91 | $2,528 | $1,628 | 64.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 44 | 44 | $1,922 | $1,246 | 64.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 23 | 24 | $1,800 | $1,015 | 56.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 13 | 25 | $1,000 | $410.28 | 41.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 11 | 11 | $437.00 | $312.64 | 71.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 22 | 26 | $1,417 | $267.80 | 18.9% |
About Dr. Lauren Heagy, M.D
Dr. Lauren Heagy, M.D is a Family Medicine healthcare provider based in Shrewsbury, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/08/2012. The National Provider Identifier (NPI) number assigned to this provider is 1972862258.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lauren Heagy, M.D has received a total of $2,442 in payments from pharmaceutical and medical device companies, with $158.96 received in 2022. These payments were reported across 177 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,442).
As a Medicare-enrolled provider, Heagy has provided services to 2,612 Medicare beneficiaries, totaling 3,400 services with total Medicare billing of $228,129. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Shrewsbury, PA
- Active Since 05/08/2012
- Last Updated 12/20/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1972862258
Products in Payments
- TRULICITY (Drug) $191.95
- Ozempic (Drug) $128.69
- FARXIGA (Drug) $104.35
- SHINGRIX (Biological) $101.90
- ANORO (Drug) $98.94
- Trintellix (Drug) $72.13
- TRINTELLIX (Drug) $71.00
- LINZESS (Drug) $68.06
- TRELEGY ELLIPTA (Drug) $63.76
- Aimovig (Biological) $63.53
- TOUJEO (Drug) $54.72
- Saxenda (Drug) $54.44
- Vascepa (Drug) $53.60
- NEXPLANON (Drug) $52.39
- BREO (Drug) $50.86
- Wegovy (Drug) $49.00
- Victoza (Drug) $47.97
- VIBERZI (Drug) $46.26
- Xofluza (Drug) $46.17
- SOLIQUA 100/33 (Biological) $44.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Shrewsbury
Dr. Adedamola Falokun, M.d, M.D
Family Medicine — Payments: $75,582
Nandita Kinley, M.d, M.D
Family Medicine — Payments: $1,813
Amy Pedone, M.d, M.D
Family Medicine — Payments: $1,307
Mary Mccotter Desi, M.d, M.D
Family Medicine — Payments: $1,100
Dr. Jessica Starner, M.d, M.D
Family Medicine — Payments: $970.90
Claudia Huegel, M.d, M.D
Family Medicine — Payments: $918.17